BR112021016597A2 - Diagnóstico ou prognóstico de eventos adversos pós-cirúrgicos - Google Patents

Diagnóstico ou prognóstico de eventos adversos pós-cirúrgicos

Info

Publication number
BR112021016597A2
BR112021016597A2 BR112021016597A BR112021016597A BR112021016597A2 BR 112021016597 A2 BR112021016597 A2 BR 112021016597A2 BR 112021016597 A BR112021016597 A BR 112021016597A BR 112021016597 A BR112021016597 A BR 112021016597A BR 112021016597 A2 BR112021016597 A2 BR 112021016597A2
Authority
BR
Brazil
Prior art keywords
post
adverse
event
surgical
surgery
Prior art date
Application number
BR112021016597A
Other languages
English (en)
Portuguese (pt)
Inventor
Darius Wilson
Henrik Andersson
Michelle Chew
Original Assignee
Brahms Gmbh
Linkoeping Univ Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brahms Gmbh, Linkoeping Univ Hospital filed Critical Brahms Gmbh
Publication of BR112021016597A2 publication Critical patent/BR112021016597A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR112021016597A 2019-02-21 2020-02-21 Diagnóstico ou prognóstico de eventos adversos pós-cirúrgicos BR112021016597A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19020082 2019-02-21
PCT/EP2020/054652 WO2020169819A1 (en) 2019-02-21 2020-02-21 Diagnosis or prognosis of postsurgical adverse events

Publications (1)

Publication Number Publication Date
BR112021016597A2 true BR112021016597A2 (pt) 2021-11-03

Family

ID=65529223

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021016597A BR112021016597A2 (pt) 2019-02-21 2020-02-21 Diagnóstico ou prognóstico de eventos adversos pós-cirúrgicos

Country Status (7)

Country Link
US (1) US20220187313A1 (https=)
EP (1) EP3928099A1 (https=)
JP (2) JP2022521390A (https=)
CN (1) CN113424065A (https=)
BR (1) BR112021016597A2 (https=)
CA (2) CA3295270A1 (https=)
WO (1) WO2020169819A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240221958A1 (en) * 2021-04-30 2024-07-04 Roche Diagnostics Operations, Inc. Pct marker panels for early detection of sepsis
WO2022229438A2 (en) * 2021-04-30 2022-11-03 F. Hoffmann-La Roche Ag Il6 marker panels for early detection of sepsis
EP4351636A4 (en) * 2021-06-02 2025-04-23 Washington University Systems and methods for multimodal analysis of surgical drain fluid using interchangeable and customizable nucleic acid based tests
US12152280B2 (en) 2021-09-20 2024-11-26 Droplet Biosciences, Inc. Drain fluid for diagnostics
JP2023111774A (ja) * 2022-01-31 2023-08-10 国立研究開発法人国立循環器病研究センター 再灌流療法の適用を決定するバイオマーカー
KR20250077078A (ko) * 2023-11-23 2025-05-30 (의) 삼성의료재단 비심장 수술 후 심장 트로포닌 수치를 예측하기 위한 방법 및 장치
KR20250077079A (ko) 2023-11-23 2025-05-30 (의) 삼성의료재단 비심장 수술 후 심근 손상을 예측하기 위한 방법 및 장치
WO2026013199A1 (en) 2024-07-12 2026-01-15 Cezanne S.A.S. Clinical immunoassay with early signal measurement
KR102750097B1 (ko) * 2024-07-29 2025-01-03 가천대학교 산학협력단 심혈관 시술 이후 환자의 합병증 예측 및 추적 관리 시스템 및 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570703B1 (fr) 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
US4882733A (en) 1987-03-13 1989-11-21 Ford Aerospace Corporation Method and apparatus for combining encoding and modulation
FR2664699B1 (fr) 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
ATE312351T1 (de) 2004-02-13 2005-12-15 Brahms Ag Verfahren zur bestimmung der bildung von endothelinen zu zwecken der medizinischen diagnostik, sowie antikörper und kits für die durchführung eines solchen verfahrens
US9012151B2 (en) * 2006-11-09 2015-04-21 B.R.A.H.M.S. Gmbh Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin
DE102006060112A1 (de) * 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
JP5711131B2 (ja) * 2008-10-07 2015-04-30 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 最初の有害事象の予測のためのバイオマーカー
WO2014018464A1 (en) * 2012-07-23 2014-01-30 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of sepsis
GB201402293D0 (en) * 2014-02-11 2014-03-26 Secr Defence Biomarker signatures for the prediction of onset of sepsis
ES2944613T3 (es) * 2017-02-02 2023-06-22 Brahms Gmbh proADM y/o histonas como marcadores indicadores de un acontecimiento adverso
JP6855118B2 (ja) * 2017-03-14 2021-04-07 東ソー株式会社 全身状態の良不良を評価するための情報を提供する方法及び測定試薬
EP3438668A1 (en) * 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections

Also Published As

Publication number Publication date
JP2025019061A (ja) 2025-02-06
CN113424065A (zh) 2021-09-21
CA3126202A1 (en) 2020-08-27
CA3295270A1 (en) 2026-03-02
US20220187313A1 (en) 2022-06-16
JP2022521390A (ja) 2022-04-07
WO2020169819A1 (en) 2020-08-27
EP3928099A1 (en) 2021-12-29

Similar Documents

Publication Publication Date Title
BR112021016597A2 (pt) Diagnóstico ou prognóstico de eventos adversos pós-cirúrgicos
Whittaker et al. Urine heteroplasmy is the best predictor of clinical outcome in the m. 3243A> G mtDNA mutation
Janco et al. Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer
Galil et al. Baseline serum level of matrix metalloproteinase‐3 as a biomarker of progressive joint damage in rheumatoid arthritis patients
Rang et al. miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma
Yang et al. The prospective evaluation of viral loads in patients with severe fever with thrombocytopenia syndrome
Olivieri et al. Early treatment in early undifferentiated arthritis
Toorop et al. The relationship between DOAC levels and clinical outcomes: the measures tell the tale
Liu et al. Plasma levels of microRNA-221 (miR-221) are increased in patients with acute pulmonary embolism
Panina et al. Circulating levels of proinflammatory mediators as potential biomarkers of post-traumatic knee osteoarthritis development
Magetsari et al. Deep vein thrombosis in elderly patients following surgery for fracture of the proximal femur
Broen et al. Predicting the need for further thrombosis diagnostics in suspected DVT is increased by using age adjusted D-dimer values
Xiang et al. The predictive value of circulating microRNAs for venous thromboembolism diagnosis: a systematic review and diagnostic meta-analysis
Meng et al. Incidence and risk factor for preoperative deep vein thrombosis (DVT) in isolated calcaneal fracture, a prospective cohort study
Liu et al. The voltage-gated sodium channel Nav1. 7 associated with endometrial cancer
Yang et al. The clinical value of circulating miR-99a in plasma of patients with acute myocardial infarction
Qiao et al. Serum dickkopf-1 as a clinical and prognostic factor in non-small cell lung cancer patients with bone metastases
JP2017536085A (ja) 癌の再発リスクを予測する方法
Dugdale et al. Laboratory value effectiveness in predicting early postoperative periprosthetic joint infection after total hip arthroplasty
Zhou et al. Effect of neutrophil-to-lymphocyte ratio on short-term prognosis of elderly patients with hip fracture
Li et al. Integrating pre-and post-treatment Plasma Epstein-Barr Virus DNA levels for better prognostic prediction of Nasopharyngeal Carcinoma
Caglar et al. Presepsin (sCD14-ST): could it be a novel marker for the diagnosis of ST elevation myocardial infarction?
Joo et al. Predictors of severe radiographic progression in patients with early rheumatoid arthritis: a prospective observational cohort study
Yenibertiz et al. Is Onodera’s prognostic nutritional index (OPNI) a prognostic factor in small cell lung cancer (SCLC)?
Zhang et al. Validation of an immunoassay to measure plasminogen-activator inhibitor-1 concentrations in human saliva

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]